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Abstract
Background: Thyroid Imaging Reporting and Data System (TIRADS) was developed to improve patient management and
cost-effectiveness by avoiding unnecessary fine needle aspiration biopsy (FNAB) in patients with thyroid nodules. However,
its clinical use is still very limited. Strain elastography (SE) enables the determination of tissue elasticity and has shown
promising results for the differentiation of thyroid nodules.
Methods: The aim of the present study was to evaluate the interobserver agreement (IA) of TIRADS developed by Horvath
et al. and SE. Three blinded observers independently scored stored images of TIRADS and SE in 114 thyroid nodules (114
patients). Cytology and/or histology was available for all benign (n=99) and histology for all malignant nodules (n=15).
Results: The IA between the 3 observers was only fair for TIRADS categories 2–5 (Cohens kappa=0.27,p=0.000001) and
TIRADS categories 2/3 versus 4/5 (ck=0.25,p=0.0020). The IA was substantial for SE scores 1–4 (ck=0.66,p,0.000001) and
very good for SE scores 1/2 versus 3/4 (ck=0.81,p,0.000001). 92–100% of patients with TIRADS-2 had benign lesions, while
28–42% with TIRADS-5 had malignant cytology/histology. The negative-predictive-value (NPV) was 92–100% for TIRADS
using TIRADS-categories 4&5 and 96–98% for SE using score ES-3&4 for the diagnosis of malignancy, respectively. However,
only 11–42% of nodules were in TIRADS-categories 2&3, as compared to 58–60% with ES-1&2.
Conclusions: IA of TIRADS developed by Horvath et al. is only fair. TIRADS and SE have high NPV for excluding malignancy
in the diagnostic work-up of thyroid nodules.
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Introduction
In regions with inadequate iodine supply thyroid nodules are a
common finding and are reported in one third of unselected adults
[1]. Ultrasound is an accurate method for the detection of thyroid
nodules, but it has a low accuracy for the differentiation between
benign and malignant thyroid nodules [2]. Therefore, fine-needle-
aspiration-biopsy (FNAB) is presently recommended as additional
diagnostic method in the evaluation of thyroid nodules with a size
of $10 mm in patients with normal thyroid stimulating hormone.
In addition, FNAB is advised in nodules smaller than 10 mm with
suspicious history or suspicious ultrasound findings [3–6]. Never-
theless, FNAB is known to have a high specificity (60–98%) but
varying sensitivity (54–90%) for the diagnosis of malignant thyroid
nodules [7–10]. Therefore a relevant number of patients with the
final diagnosis of benign thyroid nodules receive thyroid surgery
more for diagnostic than for therapeutic purposes.
Thyroid Imaging Reporting and Data System (TIRADS) has
been developed based on the concepts of Breast Imaging
Reporting and Data System (BIRADS), which established different
categories according to the percentage of malignancy. BIRADS
has become a worldwide accepted method that guides clinical
management of breast lesions. The aim of TIRADS was to
improve patient management and cost-effectiveness by avoiding
unnecessary fine needle aspiration biopsy FNAB in patients with
thyroid nodules. Sensitivity, specificity, positive predictive value
(PPV), negative predictive value (NPV) were 88%, 49%, 49%, and
88%, respectively. However, since its publication by Hovarth in
JCEM [11] its clinical use is still very limited and its practicability
in clinical practice is questioned.
A classical criterion of malignancy is a hard or firm consistency
upon palpation or ultrasound-probe pressure[4,12]. Previously this
attribute was subjective and dependent on the experience of the
examiner. However, with the introduction of strain elastography
(SE) a reproducible qualitative and semi-quantitative assessment of
tissue consistency became available. A meta-analysis of SE
reported a mean sensitivity and specificity for the diagnosis of
malignant thyroid nodules of 92%, and 90%, respectively[13].
PLOS ONE | www.plosone.org 1 October 2013 | Volume 8 | Issue 10 | e77927Nevertheless recently SE was challenged and criticized for its
operator dependency [14].
The aim of the present study was to evaluate the interobserver
agreement (IA) of TIRADS and SE for the assessment of thyroid
nodules.
Materials and Methods
Ethics statement: Informed written consent was obtained from
all patients and the study was performed in accordance with the
ethical guidelines of the Helsinki Declaration and approved by the
ethics committee of the medical faculty of the university of
Frankfurt.
During the previous prospective comparative study of strain
elastography and Acoustic Radiation Force Impulse imaging
thyroid ultrasound and elastography images were stored [15].
Three blinded observers with at least 5 years experience in thyroid
ultrasound independently scored the images of 114 nodules from
114 patients in regard to TIRADS classification and strain
elastography. Inclusion criteria were the presence of a thyroid
nodule $5 mm, normal values of thyroid-stimulating hormone,
and FNAB of this nodule performed within the last 6-months or
FNAB and/or surgery planned at the time of ultrasound
examination and finally performed within the study period.
Exclusion criteria were cystic lesions of completely liquid nature,
no cytology by FNAB or histology by surgery of the thyroid nodule
within the study period, indeterminate cytology by FNAB without
repeated FNAB, and suspicious or malignant cytology by FNAB
without thyroid operation within the study period. After excluding
patients without adequate reference method (nondiagnostic
aspirate on FNAB without repeated FNAB/surgery during the
study-period; suspicious or malignant aspirate on FNAB without
surgery during the study-period) stored images of B-mode, - and
Doppler Ultrasound as well as SE-images were available from 114
of the overall 138 patients. The Bethesda system was used to
report thyroid cytopathology.
Ultrasound Methods
Thyroid Imaging Reporting and Data System
(TIRADS). Thyroid ultrasound images were generated using a
9-MHz transducer (Hitachi-EUB-900,Hitachi,Tokyo,Japan). The
three observers independently scored the images according to the
TIRADS classification [11] as follows:
– TIRADS 2 (benign findings):
# Colloid type 1 nodule: Anechoic nodule with hyperechoic
spots, nonvascularized lesion
# Colloid type 2 nodule: Nonencapsulated, mixed, nonexpan-
sile nodule, with hyperechoic spots, vascularized nodule,
spongiform nodule
# Colloid type 3 nodule: Nonencapsulated, mixed nodule with
solid portion, isoechogenic, expansile, vascularized nodule
with hyperechoic spots.
– TIRADS 3 (probably benign):
# Hashimoto pseudonodule: hyper, iso, or hypoechoic,
partially encapsulated nodule with peripheral vasculariza-
tion,
– TIRADS 4A (undetermined):
# Simple neoplastic pattern: Solid or mixed hyper, iso, or
hypoechoic nodule, with a thin capsule
# De Quervain pattern: Hypoechoic lesion with ill-defined
borders, without calcifications
# Suspicious neoplastic pattern: Hyper, iso, or hypoechoic,
hypervascularized, encapsulated nodule with a thick capsule,
containing calcifications (coarse or microcalcifications)
– TIRADS 4B (suspicious):
# Malignant pattern A: Hypoechoic, nonencapsulated nodule,
with irregular shape and margins, penetrating- vessels, with
or without calcifications
– TIRADS 5 (consistent with malignancy):
# Malignant pattern B: Iso or hypoechoic, nonencapsulated
nodule with multiple peripheral microcalcifications and
hypervascularization
# Malignant pattern C: Nonencapsulated, isoechoic mixed
hypervascularized nodule with or without calcifications,
without hyperechoic spots.
The observers were blinded to the results of cytology and
histology. The observers had at least 7 years experience in thyroid
ultrasound and used TIRADS classification in clinical practice for
at least 12 months prior to study inclusion.
Strain Tissue Elastography (SE). SE images were gen-
ereated using a 9-MHz transducer (Hitachi Strain Tissue
Elastography, Hitachi-EUB-900, Hitachi Medical Cooperation,
Tokyo, Japan). The probe was placed on the neck and a light
pressure of 3–4 on a scale of 0–6 arbitrary units was applied for
measurement. The region-of-interest (ROI) for the elastography
examination was selected by the operator to include the nodule
and surrounding normal thyroid tissue. In cases of cystic lesion, the
solid component of the nodule was examined to exclude artifacts
known to be caused by the cyst.
The three observers independently scored the images according
to the following elasticity classification [16,17]:
– elasticity score (ES)-1: the nodule is displayed homogeneously
in green (soft)
– ES-2: the nodule is displayed predominantly in green with few
blue areas/spots
– ES-3: the nodule is displayed predominantly in blue with few
green areas/spots
– ES-4: the nodule is displayed completely in blue (hard).
The observers were blinded to the results of cytology and
histology. Examples are shown in Figure 1 and 2.
Statistical analysis
Statistical analysis was performed using BiAS-for-Windows
(version-9.10,epsilon-2011,Frankfurt,Germany) and SigmaPlot
and SigmaStat for Windows (version 11.0, Systat Software, Inc.
Germany). Clinical and laboratory characteristics of patients were
expressed as mean6SD, median and range. Correlations were
assessed by Spearman’s correlation coefficient. The interobserver
agreement between the 3 observers was calculated using Cohens
kappa coefficient. Hereby, a kappa value of 0 corresponds to no
agreement and a kappa value of 1.0 to complete agreement.
Kappa values between 0–0.20 indicate slight agreement, 0.41–
0.60 indicate moderate agreement, 0.61-0.80 indicate substantial
agreement and 0.81–1.00 indicate excellent agreement. Sensitiv-
ity, specificity, positive and negative predictive values, and positive
likelihood ratio(LR) were calculated using ES-Score 1 & 2 and
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TIRADS 5 & 6 for malignant classification of thyroid nodules. All
tests were two-sided and use a significance level of a=5%. The
diagnostic performance of TIRADS and SE was also assessed by
receiver-operating-characteristic (ROC)-curves. The ROC-curve
represents sensitivity versus 1-specificity for all possible cut-off
values for prediction of the different fibrosis stages, respectively.
Results
Stored images of B-mode, - and Doppler Ultrasound as well as
SE-images were available for analysis from 114 nodules of 114
patients seen between Aug. 2010 to Mar. 2012. The final diagnosis
was thyroid cancer in 15 nodules/patients and benign thyroid
nodules in 99 nodules/patients. Patient characteristics are shown
in Table 1. All patients showed up with normal thyroid hormone
values.
TIRADS
TIRADS classification varied between the three observers.
Thyroid nodules were classified as TIRADS-2 in 12–45 cases,
TIRADS-3 in 0-3 cases, TIRADS-4 in 33–84 cases and TIRADS-
5 in 18–33 cases. Details and association of scoring from each
observer with the risk of malignancy are shown in Table 2.
Correlations using the Spearman correlation coefficient for
TIRADS between the three observers were 0.407
(p=0.0000080), 0.400 (p=0.000012), and 0.257 (p=0.0059),
respectively. The interobserver agreement (Cohens kappa coeffi-
cient) between the 3 observers was 0.27 (p=0.000001) for
TIRADS categories 2–5, and 0.25 (p=0.0020) for TIRADS
categories 2&3 versus 4&5, respectively. 92–100% of patients with
TIRADS-2 had benign lesions, while 28–42% with TIRADS 5
had thyroid cancer. The negative predictive value was 92–100%
for TIRADS using TIRADS categories 4&5 for the diagnosis of
Figure 1. Example of TIRADS and SE of thyroid adenoma: 10 mm nodule in the right thyroid gland classified as TIRADS 4
(consistent with malignancy) in the left image and SE 2 (predominantly green = soft; consistent with benign nodule) in the right
image. Histology revealed a benign follicular thyroid adenoma.
doi:10.1371/journal.pone.0077927.g001
Figure 2. Example of TIRADS and SE of papillary carcinoma: 10 mm nodule in the right thyroid gland classified as TIRADS 4
(consistent with malignancy) in the left image and SE 3 (predominantly blue = hard; consistent with malignancy) in the right
image. Histology revealed a papillary T2 carcinoma.
doi:10.1371/journal.pone.0077927.g002
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categories 2&3. Details are shown in Table 3.
Strain Elastography (SE)
Thyroid nodules were classified as ES-score 1 in 2–13 cases, ES-
score 2 in 55–65 cases, ES-score 3 in 27–38 cases and ES-score 4
in 9–19 cases. Details and association of scoring with the risk of
malignancy are shown in Table 2. Correlations for SE between the
three observers were 0.824 (p,0.000001), 0.793 (p,0.000001),
and 0.815 (p,0.000001), respectively. The interobserver agree-
ment (Cohens kappa coefficient) between the 3 observers for ES-
scores 1–4 was 0.66 (p,0.000001), and 0.81 (p,0.000001) for ES
1&2 versus ES 3&4. The negative predictive value was 96–98.5%
for SE using ES 3&4 for the diagnosis of malignancy. 58–60% of
nodules were scored with ES 1&2. Details are shown in Table 3.
Comparison of TIRADS and SE
Correlations between TIRADS and SE for the three observers
were 0.338 (p=0.00025), 0.301 (p=0.0012), and 0.257
(p=0.0059), respectively. The interobserver agreement (Cohens
kappa coefficient) between the 3 observers was higher for SE with
0.66 than for TIRADS with 0.27.
No significant difference of AUROC for TIRADS and SE with
respect to the DeLong test was found for observer 1 (0.89 [95%-
CI:0.83;0.94] and 0.80 [95%-CI:0.69;0.91], p=0.17) and observ-
er 3 (0.70 [95%-CI:0.56;0.83] and 0.78 [95%-CI:0.66;0.90],
p=0.34). However, AUROC for SE was significantly higher than
for TIRADS scored by observer 2 (0.61 [95%-CI: 0.47;0.75] and
0.83 [95%-CI:0.74;0.92], p=0.00014).
Discussion
The TIRADS classification used in the present study was
primarily defined and evaluated in a study with 1097 nodules [11].
Table 1. Patient characteristics.
Characteristics
Patient age (years): Mean 6 SD (range), Median 52 6 14 (18–
83), 51
Male gender, n (%) 35 (31)
Single nodule, n (%) 32 (28)
Nodule location n(%): Left; Right; Isthmus 41 (36); 71 (62);
2( 2 )
Nodule size (mm): Mean 6 SD (range), Median 19 6 12 (5–73),
17
Cytology of nodule, n (%) 96 (84)*
Histology of nodule, n (%) 39 (34)*
Final benign diagnosis: 99 (87)
Benign follicular nodule (incl.colloid, adnomatoid, etc.) 93
Follicular adenoma 6
Final diagnosis of thyroid cancer: 15 (13)
Papillary carcinoma 10
Follicular carcinoma 2
Medullary carcinoma 2
Anaplastic carcinoma 1
SD = standard deviation, * 21 patients received cytology first and were
operated thereafter, therefore cytology and histology was available in these
patients.
doi:10.1371/journal.pone.0077927.t001
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PLOS ONE | www.plosone.org 4 October 2013 | Volume 8 | Issue 10 | e77927It defined 6 categories, of which TIRADS-1 is a normal thyroid
gland without nodules, and TIRADS-6 is diagnosed by malig-
nancy on FNAB. TIRADS 2–5 are based on different B-mode and
Duplex ultrasound criteria. In this study with 1097 nodules [11]
100% of patients with thyroid nodules scored as TIRADS-2 had
benign nodules, while 87% of nodules scored TIRADS-5 were
malignant. Sensitivity, specificity, positive predictive value (PPV),
negative predictive value (NPV) for the diagnosis of malignant
thyroid nodules were 88%, 49%, 49%, and 88%, respectively. The
authors concluded that TIRADS can improve patient manage-
ment and cost-effectiveness by avoiding unnecessary fine needle
aspiration biopsy in patients with thyroid nodules. However, since
its publication in JCEM [11] its clinical use is still very limited and
its practicability in clinical practice is questioned. The definition of
TIRADS categories is complex and clinical categorization is
challenging.
Therefore, in the present study we evaluated the interobserver
agreement of TIRADS. Three blinded observers experienced in
thyroid ultrasound scored the stored images of 114 nodules. The
IA between the 3 observers was only fair for TIRADS categories
2–5 (Cohens kappa=0.27,p=0.000001) and TIRADS categories
2/3 versus 4/5 (ck=0.25,p=0.0020). This demonstrates the
difficulties of categorizing according to TIRADS. The present
study supported the high percentage of benign nodules classified as
TIRADS-2 with 92–100%. However, the percentage of malignant
nodules classified as TIRADS-5 was lower than in the primary
study of Horvath et al. [11] with only 28–42% as compared to 87–
90%. Nevertheless, the negative predictive value with 92–100% in
the present study was comparable to the study of Horvath et al.
[11] reporting a NPV of 88%. 11–42% of nodules were in
TIRADS-categories 2&3 in the present study. Therefore, the aim
of TIRADS to avoid FNABs or surgery could apply with a high
NPV in 11–42% of nodules in the present study and in 35% of
nodules in the study published by Horvath et al. [11].
Other TIRADS classifications have been published recently.
Kwak et al. [18] published a TIRADS classification based on the
number of suspicious ultrasound features. They reported an
increase of risk of malignancy with increasing number of
suspicious ultrasound features such as solid component, hypoe-
chogenicity, irregular margins, microcalcifications, and taller-than
wide shape. Park et al. [19] proposed an equation for predicting
the probability of malignancy in thyroid nodules based on 12
ultrasound features. Russ et al. [20] prospectively evaluated 4550
nodules using a six-point scale and reported a NPV of 99.7% for
TI-RADS gray-scale score and a good interobserver agreement.
In the present study we only evaluated the TIRADS classifi-
cation published by Horvath et al. Therefore, no conclusion can
be drawn concerning the other TIRADS classifications. Future
studies are necessary to compare the different TIRADS classifi-
cation systems in terms of interobserver agreement, practicability
and validity to find the optimal system for clinical work up of
thyroid nodules.
SE has become a well evaluated clinical tool enabling the
determination of tissue elasticity using ultrasound devices. SE is a
qualitative elastography method evaluating changes in ultrasound
pattern during strain and stress of direct or indirect tissue
compression. In a meta-analysis on SE including 8 studies with
overall 639 nodules a sensitivity of 92% and a specificity of 90%
was reported for the diagnosis of malignant thyroid nodules [13].
Different methods of scoring SE have been evaluated, qualitative
assessment using a 4-scale scoring system (as used in the present
study), a 5-scale scoring system and semi-quantitative scoring using
strain value, strain ratio and histograms of colour pixels [21–23].
Nevertheless, besides a lot of promising study results two recent
studies have challenged the usefulness of SE in clinical practice by
reporting no additional value as compared to qualified B-mode
ultrasound [14,24,25]. In the present study the 4-scale qualitative
elastography was evaluated. The interobserver agreement between
the three observers was substantial for SE scores 1–4 (ck=0.66,
p,0.000001) and very good for SE scores 1&2 versus 3&4
(ck=0.81, p,0.000001). Correlations for SE between the three
observers were 0.824 (p,0.000001), 0.793 (p,0.000001), and
0.815 (p,0.000001). These results are in accordance with recently
published studies reporting interobserver concordance of 0,64 and
correlation coefficients between observers of 0.73–0.79 [26,27].
The negative-predictive-value (NPV) was 92–100% for SE using
scores ES-3&4 for the diagnosis of malignancy. These results are in
accordance with previously published studies reporting NPV of
88–98% [16,17,28–31].
However, in a recently published meta-analysis the best results
were obtained by combining SE with B-mode ultrasound criteria
of malignancy [32].
A limitation of the present study was that prospectively stored
images acquired in a prospective study were analyzed retrospec-
tively. However, the stored images enabled the independent
blinded evaluation of images by three experience sonographeurs.
We would expect even lower interobserver agreement in realtime
examination during which the images might vary. Another
limitation is the high percentage (13%) of carcinoma in the
present study. However, this is a general limitation of most studies
performed at endocrinology centers with an average of even 30%
of malignant thyroid nodules [13].
In summary, the TIRADS developed by Horvath et al. and SE
have shown excellent NPV for the diagnosis of malignant thyroid
nodules in the present study. However, while good interobserver
agreement was found using SE, this was only fair using the
Table 3. Diagnostic value of TIRADS and SE for the diagnosis of malignant thyroid nodules.
Observer
Benigne
(n=99)
Cancer
(n=15) Sensitivity (%) Specificity (%) PPV (%) NPV (%) +LR
TIRADS 4–5 1 yes, no 51, 48 15, 0 100 (78;100) 48.5 (38;59) 23 (13;35) 100 (93;100) 1.941 (1.60;2.35)
2 yes, no 88, 11 14, 1 93 (68;99.8) 11 (6;19) 14 (8;22) 92 (62;99.8) 1.050 (0.90;1.22)
3 yes, no 76, 23 14, 1 93 (68;99.8) 23 (15;33) 16 (9;25) 96 (79;99.9) 1.216 (1.02;1.45)
SE 3–4 1 yes, no 34, 65 13, 2 87 (60; 98) 66 (55; 75) 28 (16;43) 97 (90;99.6) 2.524 (1.80;3.54)
2 yes, no 32, 67 14, 1 93 (68;99.8) 68 (58;77) 30 (23;42) 98.5 (92;99.9) 2.887 (2.11;3.96)
3 yes, no 34, 65 12, 3 80 (52;96) 66 (55;75) 26 (14;41) 96 (88;99) 2.329 (1.61;3.38)
doi:10.1371/journal.pone.0077927.t003
Interobserver Agreement of TIRADS and SE
PLOS ONE | www.plosone.org 5 October 2013 | Volume 8 | Issue 10 | e77927TIRADS classification by Horvath et al. in the present study.
Other TIRADS classification systems have been published, but
were not evaluated in the present study. Therefore, the conclusions
only account for TIRADS developed by Horvath et al. Future
studies are necessary to evaluate the optimal classification system
for thyroid imaging.
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